Literature DB >> 33090299

A kinetic proofreading model for bispecific protein degraders.

Derek W Bartlett1, Adam M Gilbert2.   

Abstract

Bispecific protein degraders (BPDs) engage the ubiquitin-proteasome system (UPS) to catalytically degrade intracellular proteins through the formation of ternary complexes with the target protein and E3 ubiquitin ligases. Here, we describe the development of a mechanistic modeling framework for BPDs that includes the reaction network governing ternary complex formation and degradation via the UPS. A critical element of the model framework is a multi-step process that results in a time delay between ternary complex formation and protein degradation, thereby balancing ternary complex stability against UPS degradation rates akin to the kinetic proofreading concept that has been proposed to explain the accuracy and specificity of biological processes including protein translation and T cell receptor signal transduction. Kinetic proofreading likely plays a central role in the cell's ability to regulate substrate recognition and degradation by the UPS, and the model presented here applies this concept in the context of a quantitative pharmacokinetic (PK)-pharmacodynamic (PD) framework to inform the design of potent and selective BPDs.

Entities:  

Keywords:  Kinetic proofreading; Mechanistic modeling; Targeted protein degradation; Translational pharmacology

Year:  2020        PMID: 33090299     DOI: 10.1007/s10928-020-09722-z

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  31 in total

1.  Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action.

Authors:  Kristin M Riching; Sarah Mahan; Cesear R Corona; Mark McDougall; James D Vasta; Matthew B Robers; Marjeta Urh; Danette L Daniels
Journal:  ACS Chem Biol       Date:  2018-08-30       Impact factor: 5.100

2.  DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation.

Authors:  Georg E Winter; Dennis L Buckley; Joshiawa Paulk; Justin M Roberts; Amanda Souza; Sirano Dhe-Paganon; James E Bradner
Journal:  Science       Date:  2015-05-21       Impact factor: 47.728

Review 3.  PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future.

Authors:  Mariell Pettersson; Craig M Crews
Journal:  Drug Discov Today Technol       Date:  2019-02-13

Review 4.  Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?

Authors:  Ian Churcher
Journal:  J Med Chem       Date:  2017-12-19       Impact factor: 7.446

Review 5.  Harnessing the Power of Proteolysis for Targeted Protein Inactivation.

Authors:  Rati Verma; Dane Mohl; Raymond J Deshaies
Journal:  Mol Cell       Date:  2020-01-30       Impact factor: 17.970

Review 6.  Development of targeted protein degradation therapeutics.

Authors:  Philip P Chamberlain; Lawrence G Hamann
Journal:  Nat Chem Biol       Date:  2019-09-16       Impact factor: 15.040

7.  Catalytic in vivo protein knockdown by small-molecule PROTACs.

Authors:  Daniel P Bondeson; Alina Mares; Ian E D Smith; Eunhwa Ko; Sebastien Campos; Afjal H Miah; Katie E Mulholland; Natasha Routly; Dennis L Buckley; Jeffrey L Gustafson; Nico Zinn; Paola Grandi; Satoko Shimamura; Giovanna Bergamini; Maria Faelth-Savitski; Marcus Bantscheff; Carly Cox; Deborah A Gordon; Ryan R Willard; John J Flanagan; Linda N Casillas; Bartholomew J Votta; Willem den Besten; Kristoffer Famm; Laurens Kruidenier; Paul S Carter; John D Harling; Ian Churcher; Craig M Crews
Journal:  Nat Chem Biol       Date:  2015-06-10       Impact factor: 15.040

Review 8.  Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery.

Authors:  George M Burslem; Craig M Crews
Journal:  Cell       Date:  2020-01-16       Impact factor: 41.582

Review 9.  Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.

Authors:  Ian Collins; Hannah Wang; John J Caldwell; Raj Chopra
Journal:  Biochem J       Date:  2017-03-15       Impact factor: 3.857

Review 10.  A critical evaluation of the approaches to targeted protein degradation for drug discovery.

Authors:  Rajesh Chopra; Amine Sadok; Ian Collins
Journal:  Drug Discov Today Technol       Date:  2019-03-06
View more
  3 in total

Review 1.  Major Advances in Targeted Protein Degradation: PROTACs, LYTACs, and MADTACs.

Authors:  Shanique Alabi; Craig Crews
Journal:  J Biol Chem       Date:  2021-04-08       Impact factor: 5.157

2.  Algorithmic multiscale analysis for the FcRn mediated regulation of antibody PK in human.

Authors:  Dimitris G Patsatzis; Shengjia Wu; Dhaval K Shah; Dimitris A Goussis
Journal:  Sci Rep       Date:  2022-04-13       Impact factor: 4.379

Review 3.  Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms.

Authors:  Frances P Rodriguez-Rivera; Samuel M Levi
Journal:  ACS Cent Sci       Date:  2021-06-16       Impact factor: 14.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.